文献速递妇科

早期宫颈癌前哨淋巴结定位:SENTIX前瞻性多中心研究结果

Sentinel lymph node mapping in early-stage cervical cancer: Results from the SENTIX prospective multicenter study.
PubMed 文献 · Gynecol Oncol · 2025-10-09

SENTIX前瞻性多中心研究纳入724例FIGO 2018 IA1(LVSI+)至IB2期、术前影像无可疑淋巴结的宫颈癌患者,评估前哨淋巴结(SLN)双侧检出率、解剖分布与示踪剂性能。总体双侧检出率为92.3%,吲哚菁绿(ICG)联合放射性胶体达100%;若计入定位失败病例则为84.6%。91.6%的SLN位于盆腔I水平,无主动脉旁SLN检出。

要点

  • 724例早期宫颈癌患者SLN总体双侧检出率为92.3%,ICG联合放射性胶体达100%。
  • 91.6%的SLN位于盆腔I水平,主要在外髂和髂间区域,无主动脉旁SLN。
  • 双侧检出不受BMI、组织学类型或既往锥切影响,肿瘤>2 cm时双侧率仍超过90%。

核心结论

  • SLN定位在各示踪剂和患者亚组中均显示高双侧检出率,几乎所有SLN局限于盆腔I水平,体现解剖可预测性。
  • 结果证明在≤4 cm肿瘤中SLN定位可重复,可能有助于个体化手术规划。

研究设计与样本

  • SENTIX前瞻性多中心试验,纳入FIGO 2018 IA1(LVSI+)至IB2期、术前影像无可疑淋巴结的宫颈癌患者。
  • SLN活检采用蓝染料(BD)、放射性胶体(RC)、吲哚菁绿(ICG)或其组合。
  • 仅双侧SLN检出成功且术中冰冻切片阴性者行根治性子宫切除术或保留生育功能手术。
  • SLN位置和转移状态按解剖区域记录并集中审核以确保一致性。

主要发现

  • 724例接受SLN活检的患者中,总体双侧检出率为92.3%,ICG联合RC组合最高达100%。
  • 若计入定位失败病例,双侧检出率为84.6%。
  • 91.6%的SLN位于盆腔I水平,主要在外髂和髂间区域。
  • 髂间分叉以上的SLN少见(2.7%),盆腔II水平孤立阳性SLN罕见(1.3%)。
  • 主动脉旁区域未检出SLN;双侧检出不受BMI、组织学类型或既往锥切影响;肿瘤>2 cm时检出略低但双侧率超过90%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess sentinel lymph node (SLN) bilateral detection rate, anatomical distribution, and tracer performance in early-stage cervical cancer patients undergoing primary surgery, based on data from the prospective multicenter SENTIX trial. METHODS: Patients with FIGO 2018 stage IA1 (LVSI+) to IB2 cervical cancer and no suspicious lymph nodes on preoperative imaging were enrolled in the SENTIX trial. SLN biopsy was performed using blue dye (BD), radiocolloid (RC), indocyanine green (ICG), or their combinations. Only patients with successful bilateral SLN detection and negative intraoperative frozen section proceeded to radical hysterectomy or fertility-sparing surgery. SLN locations and metastatic status were documented by anatomical region and centrally reviewed for consistency. RESULTS: Among 724 patients who underwent SLN biopsy, the overall bilateral detection rate was 92.3 %, with the highest rate (100 %) achieved using ICG and RC combination. If mapping-failure cases were considered, the bilateral detection rate would be 84.6 %. Most SLNs (91.6 %) were located at pelvic level I, predominantly in the external iliac and interiliac regions. SLNs above the interiliac bifurcation were infrequent (2.7 %), and isolated positive SLNs in pelvic level II were rare (1.3 %). No SLNs were identified in paraaortic regions. Bilateral detection was unaffected by BMI, histology, or prior conization. Although detection was slightly lower in tumors >2 cm, bilateral rates exceeded 90 %. CONCLUSIONS: SLN mapping demonstrated high bilateral detection across tracers and patient subgroups. Nearly all SLNs were confined to pelvic level I, underscoring anatomical predictability. These results demonstrate reproducible SLN mapping in tumors ≤4 cm and may help inform individualized surgical planning.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kocian R, Kohler C, Klat J, et al. Sentinel lymph node mapping in early-stage cervical cancer: Results from the SENTIX prospective multicenter study. Gynecol Oncol. 2025. PMID: 41072167. doi:10.1016/j.ygyno.2025.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。